CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Starting from the recent identification of CD36 and CD97 as a novel marker combination of fibroblast quiescence in lung during fibrosis, we aimed to survey the literature in search for facts about the separate (or concomitant) expression of clusters of differentiation CD36 and CD97 in either tumor-...
Main Authors: | Cristiana Tanase, Ancuta-Augustina Gheorghisan-Galateanu, Ionela Daniela Popescu, Simona Mihai, Elena Codrici, Radu Albulescu, Mihail Eugen Hinescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/16/5656 |
Similar Items
-
Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
by: Cristiana Tanase, et al.
Published: (2022-01-01) -
Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma
by: Fereshteh Rezagholizadeh, et al.
Published: (2024-01-01) -
Inactivation of APC Induces CD34 Upregulation to Promote Epithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer
by: Mei Jen Hsieh, et al.
Published: (2020-06-01) -
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma
by: Mahshid Panahi, et al.
Published: (2023-01-01) -
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
by: Katsuhito Teramatsu, et al.
Published: (2022-11-01)